Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets Trade with Minor Losses
Wed, 18 Mar 09:30 am

Asian stock markets gained over 1% shrugging off investors' concerns over the Fed raising the interest rates and ahead of the conclusion of the Fed's 2 day meet. Yesterday, the U.S markets closed mixed as investors' focussed towards the outcome of the Fed meeting. European markets closed on a mixed note with stock markets in Germany being the biggest loser (down 1.5%). Chinese, Hong Kong, Taiwanese and Korean markets are trading with solid gains of 1%, 1.1%, 1.02% and 0.2% respectively while the Japanese markets are trading with minimal losses of 0.1%.

Indian markets opened with moderate gains, however, quickly turned into red. BSE Sensex is trading with a minor loss of about 40 points while NSE-Nifty has lost about 15 points. BSE Mid Cap and BSE Small Cap are trading in green. Midcap stocks have gained about 5 points while smallcap stocks have gained about 32 points. consumer durables and Automobiles sector have lost the maximum.

Commodity price took a hit yesterday as Gold prices, per 10 grams, fell nearly 0.5% or Rs 164 and is trading at Rs 25,600 levels. While Silver prices, per kilogram, fell about 0.6% or Rs 208 and is currently available at Rs 35,350 levels. Crude oil prices jumped over 1% yesterday or Rs 31. Per barrel, the crude oil prices is trading at Rs 2770 levels. The exchange rate of Indian Rupee and U.S Dollar gained marginally by 0.03% or 0.02. The rupee is trading at Rs 62.72 per dollar.

Healthcare sector has witnessed gains in the early trading session. Share of Cadila healthcare gained nearly 1.5% after the company launched a new drug to treat Hepatitis C. The drug is used as Oral therapy and is named SoviHep. The drug would be marketed by Zydus Heptiza. Zydus and Gilead Sciences have partnered each other to market and sell this drug in over 91 countries that also include India. The drug would be useful in India as it is a home 10 mn Hepatitis C patients.

Metals have gained over 0.6% in the early trade. Shares of Bhushan steel gained more than 4% after the company said that they have taken initiative steps to restructure Rs 230 bn worth of long-term loans. Main lenders of the long-term loan include State Bank of India and Punjab National Bank. According to a leading financial source, these banks are also considering to extend the loan tenure to 25 years from 8 years.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets Trade with Minor Losses". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.